Serum IL-6 and TNF-? in Type 1 Diabetes Mellitus Patients in Mosul
Keywords:
Type 1 Diabetes Mellitus, IL-6, TNF—α.Abstract
The objective of the study is to evaluate the levels of IL-6 and TNF-? in sera of patients with type 1 diabetes mellitus (T1DM) compared to healthy people and correlate their levels with different factors. The results showed significant increase in the levels of IL-6 and TNF-? (P?0.05) in T1DM compared to control group. The levels of IL-6 were not significant when compared with age groups, duration of the disease and level of HbA1c. On contrast the levels of TNF-? in T1DM patients was significantly increased (P?0.05) when compared with age groups and duration of the disease but not significantly with different HbA1c.
References
Ferreira-Hermosillo A, Molina-Ayala M , Ramírez-Rentería C , Vargas G1, Gonzalez B, Isibasi A , et al.. Inflammatory Cytokine Profile Associated with Metabolic Syndrome in Adult Patients with Type 1 Diabetes. J Diabetes Res. 2015;2015:972073.
Alnek K, Kisand K, Heilman K, Peet A, Varik K, Uibo R (2015) Increased Blood Levels of Growth Factors, Proinflammatory Cytokines, and Th17 Cytokines in Patients with Newly Diagnosed Type 1 Diabetes. PLoS ONE 10(12): e0142976.
International Diabetic Federation. IDF diabetes atlas 7th ed. Brussels: International Diabetic Federation; 2015.
Eizirik DL, Sandler S, Welsh N, Cetkovic-Cvrlje M, Nieman A, Geller D A, et al.. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J Clin Invest. 1994 May; 93(5): 1968–1974.
Peraldi P, Spiegelman B. TNF-α and insulin resistance: Summary and future prospects. Molecular and Cellular Biochemistry, 1998, 182(1-2): 169-175.
Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. 1999;353(9165):1649-1652.
Erbağci AB, Tarakçioğlu M, Coşkun Y, Sivasli E, Namiduru ES. Mediators of inflammation in children with type I diabetes mellitus: cytokines in type I diabetic children. Clinical Biochemistry 2001;34(8):645-650.
Ozer G, Teker Z, Cetiner S, Yilmaz M, Topaloglu AK, Onenli-Mungan N, et al. Serum IL-1, IL-2, TNFalpha and INFgamma levels of patients with type 1 diabetes mellitus and their siblings. Journal of Pediatric Endocrinology and Metabolism 2003;16(2):203-210.
Davì G, , Chiarelli F, Santilli F, Pomilio M, Vigneri S, Falco A, et al. Enhanced Lipid Peroxidation and Platelet Activation in the Early Phase of Type 1 Diabetes Mellitus: Role of Interleukin-6 and Disease Duration . Circulation 2003;107(25):3199-3203.
Febbraio MA, Hiscock N, Sacchetti M, Fischer CP, Pedersen BK. Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes. 2004;53(7):1643-1648.
Pal M, Febbraio MA, Whitham M. From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation. Immunol Cell Biol. 2014 ;92(4):331-339.
Glund S, Deshmukh A, Long YC, Moller T, Koistinen HA, et al. Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle. Diabetes. 2007;56(6):1630-1637.
Nieto-Vazquez I, Fernández-Veledo S, de Alvaro C, Lorenzo M. Dual role of interleukin-6 in regulating insulin sensitivity in murine skeletal muscle. Diabetes. 2008;57(12):3211-3221.
Ellingsgaard H, Hauselmann I, Schuler B, Habib AM, Baggio LL, Meier DT, et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med. 2011;17(11):1481-1489.
Suzuki T, Imai J, Yamada T, Ishigaki Y, Kaneko K, Uno K, et al. Interleukin-6 enhances glucose-stimulated insulin secretion from pancreatic beta-cells: potential involvement of the PLC-IP3-dependent pathway. Diabetes. 201;60(2):537-547.
Karavanaki K1, Kakleas K, Georga S, Bartzeliotou A, Mavropoulos G, Tsouvalas M, et al. Plasma high sensitivity C-reactive protein and its relationship with cytokine levels in children with newly diagnosed type 1 diabetes and ketoacidosis. Clin Biochem. 2012;45(16-17):1383-1388.
Chen YL, Qiao YC2, Pan YH, Xu Y, Huang YC, Wang YH1, Geng LJ, et al. Correlation between serum interleukin-6 level and type 1 diabetes mellitus: A systematic review and meta-analysis. Cytokine. 2017;94:14-20.
Huang W, Wang DS, Li XY, Wu WZ,Ni GC. Expression of levels of IL-6 mRNA in PBMNCs from patients with IDDM and normal by RT-PCR procedure. Clin Chinese Med J. 1993;106(12):893-897.
Kulseng B, Skjåk-Braek G, Følling I, Espevik T. TNF production from peripheral blood mononuclear cells in diabetic patients after stimulation with alginate and lipopolysaccharide. Scand J Immunol. 1996;43(3):335-340.
Geerlings SE, Brouwer EC, Van Kessel KC, Gaastra W, Stolk RP, Hoepelman AI. Cytokine secretion is impaired in women with diabetes mellitus. Eur J Clin Invest. 2000;30(11):995-1001.
Hammed IK, Rashid NF, Abed NA. Serum interleukin-6 level in children with type 1 diabetes mellitus. J Fac Med Baghdad. 2012;54(3):228-230.
Kavitha G, Ramani G, Priya KD, Aruna RM. Oxidative stress, IL-6 and atherogenic index of plasma in diabetic nephropathy. J Appl Biol Pharm Technol . 2011;2(2)211-217.
Foss-Freitas MC, Foss NT, Donadi EA, Foss MC. Effect of the glycemic control on intracellular cytokine production from peripheral blood mononuclear cells of type 1 and type 2 diabetic patients. Diabetes Research and Clinical Practice 2008; 82,(3):329–334.
Qiao YC, Chen YL, Pan YH, Tian F, Xu Y, Zhang XX, et al. The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: A systematic review and meta-analysis. PLoS One. 2017;12(4):e0176157.
Zier KS, Leo MM, Spielman RS, Baker L. Decreased synthesis of interleukin-2 (IL-2) in insulin-dependent diabetes mellitus. Diabetes. 1984;33(6):552-5.
Netea MG, Hancu N, Blok WL, Grigorescu-Sido P, Popa L, Popa V, et al. Interleukin 1 beta, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals. Cytokine. 1997 Apr;9(4):284-287.
Downloads
Published
How to Cite
Issue
Section
License
Authors who submit papers with this journal agree to the following terms.